EL Corp Fpo News - EIM

First Patient Enrolled in AVITA Therapeutic’s Pivotal Study Evaluating the RECELL System for Repigmentation of Stable Vitil...

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...

AVITA Therapeutics to Participate in Upcoming Investor Conferences

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...

AVITA Therapeutics Provides Company Update and Revised Corporate Presentation

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform...

AVITA Therapeutics to Participate at the Canaccord Genuity 40th Annual Growth Conference

AVITA Therapeutics, Inc. (NASDAQ: RCEL) (ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...

BARDA to Initiate Procurement of the RECELL® System for Emergency Response Preparedness

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...

AVITA Therapeutics Provides Company Update and Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2020

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...

AVITA Medical Files RECELL® System Investigational Device Exemption (IDE) Application with the U.S. Food & Drug Administrati...

AVITA Medical Limited (ASX: AVH) (NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical...

AVITA Medical to Participate at the Jefferies Virtual Healthcare Conference

AVITA Medical Limited (Company) (ASX:AVH) (NASDAQ:RCEL) today announced that management will present virtually at the upcoming Jefferies Virtual...

AVITA Medical to Participate at Oppenheimer's MedTech Summit

AVITA Medical Limited (Company) (ASX:AVH) (NASDAQ:RCEL) today announced that management will participate virtually in the 1-on-1 meetings at the...

AVITA Medical Limited Proposed Redomiciliation to the United States of America – Registration of Scheme Booklet with ASIC &...

AVITA Medical Limited (Company) (ASX:AVH) (NASDAQ:RCEL) is pleased to announce that the Australian Securities and Investments Commission (ASIC...

AVITA Medical Limited Proposed redomiciliation to the United States of America – Federal Court of Australia orders convenin...

AVITA Medical Limited (Company) (ASX:AVH, NASDAQ:RCEL) is pleased to announce that the Federal Court of Australia (Court) has today approved...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

EL Corp Fpo (EIM)

Empower your portfolio: Real-time discussions and actionable trading ideas.

EIM News

First Patient Enrolled in AVITA Therapeutic’s Pivotal Study Evaluating the RECELL System for Repigmentation of Stable Vitil...

AVITA Therapeutics to Participate in Upcoming Investor Conferences

AVITA Therapeutics Provides Company Update and Revised Corporate Presentation

AVITA Therapeutics to Participate at the Canaccord Genuity 40th Annual Growth Conference

BARDA to Initiate Procurement of the RECELL® System for Emergency Response Preparedness

AVITA Therapeutics Provides Company Update and Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2020

AVITA Medical Files RECELL® System Investigational Device Exemption (IDE) Application with the U.S. Food & Drug Administrati...

AVITA Medical to Participate at the Jefferies Virtual Healthcare Conference

AVITA Medical to Participate at Oppenheimer's MedTech Summit

AVITA Medical Limited Proposed Redomiciliation to the United States of America – Registration of Scheme Booklet with ASIC &...

AVITA Medical Limited Proposed redomiciliation to the United States of America – Federal Court of Australia orders convenin...

AVITA Medical Reports Third Quarter Fiscal 2020 Financial Results and Company Update

AVITA Medical Announces Intention to Redomicile to the United States of America

AVITA Medical Provides Preliminary Top Line Results for the Third Quarter and COVID-19 Update

RECELL® System Data Accepted to 52nd Annual American Burn Association Meeting Available Online

EIM Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

EL Corp Fpo (EIM) News

EL Corp Fpo (EIM)

Empower your portfolio: Real-time discussions and actionable trading ideas.

EIM News

First Patient Enrolled in AVITA Therapeutic’s Pivotal Study Evaluating the RECELL System for Repigmentation of Stable Vitil...

AVITA Therapeutics to Participate in Upcoming Investor Conferences

AVITA Therapeutics Provides Company Update and Revised Corporate Presentation

AVITA Therapeutics to Participate at the Canaccord Genuity 40th Annual Growth Conference

BARDA to Initiate Procurement of the RECELL® System for Emergency Response Preparedness

AVITA Therapeutics Provides Company Update and Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2020

AVITA Medical Files RECELL® System Investigational Device Exemption (IDE) Application with the U.S. Food & Drug Administrati...

AVITA Medical to Participate at the Jefferies Virtual Healthcare Conference

AVITA Medical to Participate at Oppenheimer's MedTech Summit

AVITA Medical Limited Proposed Redomiciliation to the United States of America – Registration of Scheme Booklet with ASIC &...

AVITA Medical Limited Proposed redomiciliation to the United States of America – Federal Court of Australia orders convenin...

AVITA Medical Reports Third Quarter Fiscal 2020 Financial Results and Company Update

AVITA Medical Announces Intention to Redomicile to the United States of America

AVITA Medical Provides Preliminary Top Line Results for the Third Quarter and COVID-19 Update

RECELL® System Data Accepted to 52nd Annual American Burn Association Meeting Available Online

EIM Discussion

Your Recent History